Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: MarketLine (a Datamonitor Company)
$175.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Dainippon Sumitomo Pharma Co Ltd's Subsidiary Acquires Elevation Pharmaceuticals, Inc.


Wednesday, 5 Sep 2012 07:30pm EDT 

Dainippon Sumitomo Pharma Co Ltd announced that its subsidiary has fully acquired Elevation Pharmaceuticals, Inc. on September 5, 2012 (American time). 

Related Company News

Company Quote

1210.0
-9.0 -0.74%
10:30pm EDT